Oncology Nutrition Market to Reach USD 4.87 Billion by 2033, Growing at 8.9% CAGR

Oncology Nutrition Market

The Oncology Nutrition Market is projected to experience significant growth, with its value expected to rise from USD 2.07 billion in 2023 to USD 4.87 billion by 2033, reflecting an average CAGR of 8.9% during the forecast period. The increasing demand for oncology nutrition is driven by the growing recognition of the critical role medical nutrition therapy plays in cancer care.

Medical nutrition therapy (MNT) is essential for cancer patients, as it helps improve physical capacity, supports recovery during and after cancer treatments, and enhances overall quality of life. As cancer treatments often lead to side effects such as decreased appetite and malabsorption, the importance of tailored nutrition strategies is gaining prominence. This has led to a surge in the adoption of oncology nutrition products that support better treatment tolerance and improve patient outcomes.

In addition, the increasing focus on nutritional screening and evaluation is helping identify patients at higher risk of malnutrition, which is a common issue among cancer patients. This trend is encouraging healthcare providers to integrate oncology nutrition into the overall treatment plan, further driving market growth.

Key Market Insights

• Importance of Medical Nutrition Therapy: Medical nutrition therapy plays a crucial role in enhancing physical capacity, supporting patients during cancer treatments, and improving overall quality of life. This therapy is particularly vital as patients often experience decreased tolerance to cancer therapies, which drives the demand for specialized oncology nutrition products.
• Nutritional Screening and Evaluation: Identifying individuals at risk of malnutrition through nutritional screening is essential, as many cancer patients face nutritional deficiencies that can impact their treatment outcomes.

Growth Drivers

• Rising Incidence of Cancer: The increasing prevalence of cancer globally necessitates effective nutritional support for patients undergoing treatment.
• Focus on Specialized Nutrition: There is a growing recognition of the need for tailored nutritional solutions to address the unique challenges faced by cancer patients, including those undergoing chemotherapy and radiation therapy.
• Technological Advancements: Innovations in oncology nutrition products are enhancing the effectiveness and appeal of these offerings, further driving market growth.

Market Trends

• The oncology nutrition market is expected to benefit from increased research and development activities, leading to new product launches aimed at improving patient outcomes.
• North America is anticipated to hold a significant share of the market, driven by advanced healthcare infrastructure and high awareness levels regarding the importance of nutrition in cancer care.

Challenges

Despite the positive outlook, challenges such as high costs associated with premium oncology nutrition products may hinder broader adoption among patients.In summary, the oncology nutrition market is set for robust growth driven by rising cancer incidences, increased awareness of nutritional needs during treatment, and ongoing advancements in product offerings.

Request a Sample Copy Now : https://www.fmisamplereport.com/sample/rep-gb-14411

Key Takeaways:

• The Oncology Nutrition Market is expected to grow at an 8.9% CAGR, reaching USD 4.87 billion by 2033.
• The increasing recognition of the role of medical nutrition therapy in cancer treatment is a key driver for market growth.
• Nutritional screening and evaluation are becoming essential for identifying at-risk patients, boosting demand for oncology nutrition products.
• Tailored nutrition solutions are improving cancer treatment outcomes, helping patients better tolerate therapies and enhance their quality of life.

With the growing need for supportive care in cancer treatment, the oncology nutrition market is poised for continued growth, offering innovative solutions that enhance patient recovery and well-being during their cancer journey.

Oncology Nutrition Market Trend Analysis

• Creation of elemental formulations and product innovation in terms of non-GMO-based formulas.
• Shift in emphasis from parenteral to enteral nutrition.
• Rising cancer incidence, particularly the rise of patients receiving treatment for malnutrition.
• Rising demand for nutritional feeding in the homecare industry.
• Improving the quality of clinical research on nutritional interventions.

Competitive Landscape of the Oncology Nutrition Market

New product launches and continuous technological innovations are the key strategies adopted by prominent players in the oncology nutrition market. The healthcare systems organizations are changing due to new research and increased public knowledge of the advantages of oncology nutrition. Clinical nutritionists and oncologists are working more closely to improve oncology nutrition and treatment within the oncology nutrition sector.

The presence of competitors, new product debuts, and partnerships related to the industry under consideration all contribute to the market’s growth. According to the report, Esperer launched its nutrition development center in Hyderabad in 2020. The facility in Hyderabad is expected to house a variety of cohesive capabilities, such as investigative workrooms and product development sub-centers, with a dedicated laboratory for analyzing sensory components, packing, and taste.

The leading firms worldwide for oncology nutrition are focused on obtaining regulatory clearances, developing cutting-edge goods, introducing new products, and partnering with and acquiring other businesses. The global market for oncology nutrition is projected to expand due to these leading players’ tactics. The following are a few expansion methods used by companies in the oncology nutrition market:

• To increase its presence in medical nutrition, Nestle acquired the Allergan business in January 2020.
• Smartfish AS and B. Braun worked together to introduce Remune, a medicinal nutrition solution, in September 2019. In 2019 and 2020, B. Braun introduced Remune in over 20 nations. Several other markets in Europe, Asia, and South America followed.
• Ina, the intelligent nutrition helper, was introduced by CancerCare in collaboration with Savor Health in 2019. The Ina offers tailored, evidence-based nutrition counseling to help cancer patients eat well and stay fed during treatment.
• A three-chamber bag with a unique protein-to-energy ratio called mofKabiven additional Nitrogen was introduced by Fresenius Kabi AG in 2018 in Europe.
• The SmartPN tool was introduced in October 2018 by Baxter International Inc. and the American Society for Parenteral and Enteral Nutrition (ASPEN) to reduce clinical malnutrition.

Key Players in the Oncology Nutrition Market

• FMC Corporation
• Danone India
• Abbott
• Aceto
• B. Braun Melsungen AG
• Baxter
• Fresenius Kabi AG
• Global Health Products, Inc.
• Hormel Foods Corporation
• Mead Johnson & Company, LLC
• Meiji Holdings Co., Ltd
• Nestlé S.A.
• BioSig Technologies, Inc.
• Auris Health, Inc.

Key Companies Profiled

FMC Corporation; Danone India; Abbott; Aceto; B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Mead Johnson & Company, LLC; Meiji Holdings Co., Ltd; Nestlé S.A.; BioSig Technologies, Inc.; Auris Health, Inc.

Key Segments

By Cancer Type:

• Head & Neck Cancer
• Stomach & Gastrointestinal Cancers
• Blood Cancer
• Breast Cancer
• Lung Cancer
• Other cancers

By End Use:

• Hospitals & Clinics
• Home Care
• Others

By Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific
• Latin America
• The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube